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Abstract
Dysfunction of CFTR in cystic fibrosis (CF) airway epithelium perturbs the normal regulation of ion transport, leading to a
reduced volume of airway surface liquid (ASL), mucus dehydration, decreased mucus transport, and mucus plugging of the
airways. CFTR is normally expressed in ciliated epithelial cells of the surface and submucosal gland ductal epithelium and
submucosal gland acinar cells. Critical questions for the development of gene transfer strategies for CF airway disease are
what airway regions require CFTR function and how many epithelial cells require CFTR expression to restore normal ASL
volume regulation and mucus transport to CF airway epithelium? An in vitro model of human CF ciliated surface airway
epithelium (CF HAE) was used to test whether a human parainfluenza virus (PIV) vector engineered to express CFTR
(PIVCFTR) could deliver sufficient CFTR to CF HAE to restore mucus transport, thus correcting the CF phenotype. PIVCFTR
delivered CFTR to .60% of airway surface epithelial cells and expressed CFTR protein in CF HAE approximately 100-fold
over endogenous levels in non-CF HAE. This efficiency of CFTR delivery fully corrected the basic bioelectric defects of Cl2
and Na+ epithelial ion transport and restored ASL volume regulation and mucus transport to levels approaching those of
non-CF HAE. To determine the numbers of CF HAE surface epithelial cells required to express CFTR for restoration of mucus
transport to normal levels, different amounts of PIVCFTR were used to express CFTR in 3%–65% of the surface epithelial cells
of CF HAE and correlated to increasing ASL volumes and mucus transport rates. These data demonstrate for the first time, to
our knowledge, that restoration of normal mucus transport rates in CF HAE was achieved after CFTR delivery to 25% of
surface epithelial cells. In vivo experimentation in appropriate models will be required to determine what level of mucus
transport will afford clinical benefit to CF patients, but we predict that a future goal for corrective gene transfer to the CF
human airways in vivo would attempt to target at least 25% of surface epithelial cells to achieve mucus transport rates
comparable to those in non-CF airways.
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Introduction
Cystic fibrosis (CF) is the most common recessive lethal genetic
disorder in Caucasian populations and results from a defect in the
CFTR gene. Although CF affects many organs, the pulmonary
manifestations account for over 90% of the morbidity and
mortality [1]. Dysfunction of CFTR in CF airway epithelium
perturbs the normal regulation of ion transport, leading to a
reduced volume of airway surface liquid (ASL), mucus dehydra-
tion, decreased mucus transport (MCT), and mucus plugging of
the airways, which are hallmarks of early CF lung disease. Failure
of effective mucus clearance initiates and exacerbates CF lung
disease, resulting in an inability to effectively prevent or eradicate
bacterial infection, typically dominated by Pseudomonas aeruginosa.
Persistent neutrophil-mediated inflammation in CF airways
further compromises defective clearance and, over several
decades, results in airway destruction and fatal decline of lung
function.
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Airway mucus clearance is dependent on MCT facilitated by
ciliated cell function and cough clearance, and constitutes
‘‘mechanical’’ innate defense of the lung [2]. Both MCT and
cough clearance require sufficient hydration of mucus secretions
for effective airway clearance. The currently accepted model for
CF lung pathogenesis is that absence of CFTR function leads to
ASL volume reduction that results in mucostasis. A logical
therapeutic strategy to reverse CF lung pathogenesis would
therefore replace CFTR function to CF airway epithelium,
restoring ASL volume regulation and MCT. CFTR gene delivery
strategies remain a rational approach towards this goal. To date,
however, clinical trials in CF patients using CFTR gene delivery
techniques have resulted in limited successful gene delivery that is
widely considered to be insufficient for therapeutic benefit to CF
patients. The fundamental hurdle to these approaches is the low
efficiency of CFTR gene delivery to human conducting airway
epithelial cells that regulate MCT.
In non-CF human airways, CFTR is expressed in ciliated
airway epithelial cells of the surface and submucosal gland ductal
epithelium [3], and in the fluid-secreting cells of the submucosal
glands [4]. Ciliated cells are the predominant luminal epithelial
cell type present throughout the proximal and distal conducting
airways and are critical cell types for facilitating MCT [5]. These
properties of ciliated cells make them an abundant and relevant
target for CFTR gene delivery. Since restoration of MCT or ASL
volumes to normal non-CF levels has not been described after
delivery of CFTR to CF airway epithelium either in vitro or in
vivo, it remains unknown how much CFTR or how many surface
epithelial cells will be required to express CFTR to restore
mechanical innate defense to the airways.
In vitro models of human ciliated airway epithelium (HAE)
recapitulate the morphology and physiology of the human airway
epithelium and have been a valuable tool in the study of cell
physiologic mechanisms that regulate ion and fluid transport and
MCT in the human ciliated conducting airways [6–8]. Impor-
tantly, HAE retain phenotypic differences between non-CF and
CF airway epithelium, i.e., CF HAE exhibit reduced or absent
cAMP-mediated chloride ion (Cl2) secretion, dysregulation of
sodium ion (Na+) absorption, excessive ASL absorption, dehydra-
tion of secreted mucus, and mucostasis [6]. This model has been
predictive of the in vivo efficacy of drug- and gene-based
therapeutics in human clinical studies [9–16]. In particular, this
model has been utilized to determine that currently available gene
transfer vectors approved for clinical testing (e.g., adenovirus,
lentivirus, AAV, and nonviral vectors) are inefficient at delivering
CFTR to sufficient numbers of surface epithelial cells to restore
CFTR function or ASL volume for effective MCT. The target
number of cells in a ciliated airway epithelium needed to express
CFTR for restoration of ASL and MCT is currently unknown.
We have shown that human parainfluenza virus (PIV)
selectively targets ciliated cells of HAE after luminal delivery
[17]. Since recombinant PIV can be re-engineered to express large
transgene inserts [18], we used PIV to: (1) generate PIV-expressing
CFTR as an additional gene (PIVCFTR); (2) test whether delivery
of CFTR to CF ciliated cells restored mechanical innate defense,
i.e., MCT, to human CF airway epithelia; and (3) determine the
numbers of CF epithelial cells requiring CFTR to restore MCT
rates to normal non-CF HAE levels. Using CF HAE, CFTR
expression levels per cell and numbers of cells expressing CFTR
were correlated with correction of ion transport, ASL volume
regulation, and MCT rates to assess the relationship between gene
transduction and restoration of normal mucociliary transport. We
show that PIV-mediated delivery of CFTR to ciliated cells of CF
HAE resulted in functional CFTR channel activity with
restoration of ASL volume homeostasis and MCT. Further, we
show that CFTR expression in individual ciliated cells does not
require tight regulation of expression and that restoration of MCT
rates to those measured in non-CF HAE required CFTR delivery
to at least 25% of surface epithelial cells or approximately 30% of
ciliated cells. Hence, we describe the first demonstration, to our
knowledge, of efficient CFTR gene delivery to CF ciliated airway
epithelium that is sufficient to correct the fundamental physiolog-
ical dysfunctions that precipitate CF lung pathogenesis.
Results
Efficient CFTR Delivery to Ciliated Airway Epithelium by PIV
Recombinant PIV-expressing GFP (PIVGFP) infects ciliated cells
of an in vitro model of human airway epithelium that recapitulates
the morphology of the human ciliated airway epithelium in vivo
(Figure 1A, 1B, and 1C). Inoculation of freshly excised human
tracheobronchial airway epithelium showed PIVGFP also targeted
ciliated cells under noncultured conditions (Figure 1D).
To express CFTR in CF ciliated cells, a PIV with CFTR
inserted into the viral genome was constructed (PIVCFTR, Figure
S1). Apical surface inoculation of CF HAE with PIVCFTR or
PIVGFP at 106 plaque-forming units (PFU) (100 ml of 107 PFU/
ml for 2 h: multiplicity of infection [MOI] ,3 for all lumenal cells
and ,5 for ciliated cells) resulted in infection of a significant
number of cells 48 h postinoculation (pi) as detected by
immunolocalization of PIV fusion (F) glycoprotein viewed en face
(Figure 2A and 2B). Immunolocalization of PIV-mediated GFP
and PIV F expressed by PIVGFP or F glycoprotein expressed by
PIVCFTR confirmed targeting of ciliated cells (Figure 2C and
2D). Quantitation of lumenal cells infected by PIVGFP or
PIVCFTR revealed that similar numbers of ciliated cells were
infected by each virus (Figure 2E). Although ciliated cell numbers
were variable in HAE derived from different donors (range 60% to
80%), the percentage of ciliated cells per square centimeter of
epithelium surface area determined by b-tubulin IV immunode-
tection showed that on average approximately 70% of surface cells
Author Summary
The ciliated epithelium that lines the conducting airways
of the lung normally functions to transport hydrated
mucus secretions out of the airways to maintain respira-
tory sterility. Cystic fibrosis (CF) lung disease results from
reduced airway surface hydration leading to decreased
mucus clearance that precipitates bacterial infection and
progressive obstructive lung disease. CF is a genetic
disease, and the mutant protein is a chloride ion channel
(CFTR) that normally regulates ion and fluid transport on
the airway surface. Restoration of corrected CFTR function
to the airway epithelium of CF patients by delivering a new
CFTR gene to airway epithelial cells has long been
envisioned as a therapeutic strategy for CF lung disease.
Towards this goal, we use a novel viral vector to deliver
CFTR to a culture model that represents the ciliated airway
epithelium of CF patients and show that this strategy
restores airway surface hydration and mucus transport to
levels of that in non-CF individuals. This study demon-
strates efficient and efficacious CFTR delivery to CF ciliated
airway epithelium and that CFTR delivered to approxi-
mately 25% of the surface epithelial cells restores normal
levels of airway surface hydration and mucus transport.
These studies serve as a benchmark for the efficiency of
CFTR gene delivery to CF airways for future CF gene
therapy studies in vivo.
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were ciliated cells. Since the total number of lumenal surface cells
in HAE approximates 0.36106 cells, we estimate that approxi-
mately 42% of surface cells or approximately 60% of ciliated cells
were infected by PIV under these conditions.
The PIV vector replicates in ciliated cells and by 24 h pi, sheds
progeny virions onto the culture surface, resulting in further
rounds of ciliated cell infection. However, when low viral titers
(103 PFU) were used to inoculate HAE, evidence of further rounds
of infection (i.e., spread) was not apparent until 48 h pi [17]. To
determine whether the high efficiency of ciliated cell infection by
PIVCFTR was dependent on spread of progeny virus from ciliated
cell to ciliated cell, we compared infection rates at 24 h versus
48 h pi. HAE inoculated with PIVCFTR (106 PFU) for 2 h
showed similar high infection rates at 24 h pi as for 48 h (2-h data
for Figure 2F vs. 2E), indicating that the initial high titer inoculum
and not cell–cell spread of virus mediated the highly efficient
targeting of ciliated cells by PIV. Prolonging or decreasing
inoculation times to 8 h or 5 min produced modestly increased
or decreased infection rates, respectively (Figure 2F). The high
numbers of PIVCFTR-infected cells with only 5-min inoculation
time highlight the high efficiency of PIV infection and suggest that
short exposure times in the airways will be sufficient for efficient
targeting of ciliated cells in vivo.
Although equally efficient at targeting ciliated cells as PIVGFP,
PIVCFTR stimulated significantly lower amounts of epithelial cell-
derived inflammatory mediators associated with in vivo viral
pathogenesis. Indeed, PIVCFTR only induced inflammatory
mediator secretion to levels stimulated by inoculation with UV-
inactivated PIV (Figure 2G for CXCL8, and Figure S2 for
CXCL10, IL-6, IL-12p40, MCP-1, and RANTES). Since
PIVCFTR produced 10-fold fewer progeny virions than PIVGFP
due to the insertion of the relatively large CFTR insert (Figure 2H),
it is likely that the generation of inflammatory mediators is
proportional to the rate of PIV replication in ciliated cells.
PIV Delivers CFTR to Ciliated Cells, Resulting in
Overexpression and Apical Localization of Functional
CFTR
Expression levels of transduced CFTR in CF HAE were
determined by comparing the levels of exogenous CFTR mRNA
Figure 1. Infection of human ciliated cells by PIV in vitro and ex vivo. (A) Scanning electron micrograph of HAE showing cilia and mucus on
the luminal surface. (B) Histological cross-section of HAE showing pseudostratified, columnar airway epithelium with ciliated (cc) and mucin-secreting
cells (mc) and basal epithelial cells (bc). (C) Representative confocal XZ sections of HAE or (D) histological sections of human tracheobronchial tissue
inoculated with PIVGFP (106 PFU) and GFP expression assessed at 24 h pi. GFP was detected by indirect immunofluorescence with rabbit anti-GFP
polyclonal antibodies (Ab) and goat anti-rabbit IgG-fluorescein (green). Ciliated cells were identified using mouse primary Ab against acetylated a-
tubulin and detected with anti-mouse IgG-Texas Red (red). GFP colocalized to cells that were also positive for acetylated a-tubulin, confirming the
targeting of ciliated cells in vitro and ex vivo by PIV. Bar represents 20 mm in (A); and 5 mm in (B, C, and D).
doi:10.1371/journal.pbio.1000155.g001
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expressed by PIVCFTR relative to endogenous CFTR mRNA in
CF HAE and non-CF HAE using quantitative RT-PCR.
Previously, it has been estimated that human airway cells contain
only approximately 10 CFTR transcripts/cell [19]. In our
experiments, we found that CF HAE inoculated with PIVCFTR
produced a 236-fold increase in CFTR mRNA when compared to
cultures inoculated with PIVGFP or mock (Figure 3A). Since this
large-fold increase in CFTR mRNA is in part reflective of the low
endogenous copy number of CFTR, we also assessed CFTR
protein levels semiquantitatively by western blot. CF HAE
Figure 2. Efficient targeting of CF ciliated cells by PIVCFTR. (A–D) Representative immunodetection of human PIV fusion (F) glycoprotein
(red) (A and B) en face or (C and D) in histological sections of CF HAE 48 h pi with PIVGFP (A and C) or PIVCFTR (B and D). F glycoprotein was detected
by indirect immunofluorescence with a murine monoclonal anti-F Ab and anti-mouse IgG conjugated to AlexaFluor 594 (red). GFP-positive cells were
identified in histological sections (C), using rabbit anti-GFP conjugated to fluorescein (green). Fluorescence was viewed using a Texas Red filter only
(A and B) or a combined Texas Red-FITC-UV-filter (C and D). Bars represent 200 mm and 10 mm for (A and B, and C and D), respectively. (E and F)
Quantitation of (E) numbers of PIV F-positive ciliated cells showing that PIVGFP and PIVCFTR infect similar numbers of ciliated cells at 48 h pi (n= 8);
and (F) the efficiency of ciliated cell infection by PIVCFTR assessed at 24 h was similar with 5-min, 2-h, or 8-h inoculation times (n=6). (G) CXCL8
protein levels secreted by HAE 48 h pi with mock, UV-inactivated PIV, PIVGFP, or PIVCFTR showing reduced levels for PIVCFTR versus PIVGFP.
Responses positive/negative of the abscissa reflect CXCL8 secretion into apical/basolateral compartments, respectively (n=5 for each). (H) Viral titers
in apical compartment at 48 h pi for PIVGFP (green) and PIVCFTR (red) showing attenuated growth of PIVCFTR (n= 5 for each). An asterisk (*) denotes
p,0.05; ns, not significantly different. Error bars indicate SEM .
doi:10.1371/journal.pbio.1000155.g002
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Figure 3. Expression of functional CFTR in CF ciliated cells targeted by PIV. (A) CFTR mRNA levels in CF HAE 48 h after inoculation with
PIVGFP or PIVCFTR and relative to mRNA levels in CF HAE mock-inoculated (n=12). (B) Representative western blot of CFTR protein in lysates of CF
HAE 48 h pi with mock (lane 1), PIVGFP (lane 2), and PIVCFTR (lanes 3–5), with lanes 4 and 5 representing serial 10-fold dilution of cell lysates. For
comparison, non-CF HAE lysates also were included to detect endogenous CFTR levels (lane 6). Markers indicate the fully glycosylated mature form of
CFTR (Band C) and immature nonglycosylated CFTR (Band B). Data are representative of experiments with cells derived from two separate patients.
(C) Representative confocal images of CFTR immunoreactivity in CF HAE (i and ii), and non-CF HAE (iii and iv), 48 h after inoculation with PIVGFPCFTR
(i and iii) or PIVGFP (ii and iv). CFTR was detected with CFTR monoclonal Ab (clone 596) and secondary Abs conjugated to AlexaFluor 594 (red). CF
HAE inoculated with PIVGFPCFTR (i) showed immunolocalization of CFTR at apical domains of ciliated cells that were also GFP-positive, but not in
GFP-negative ciliated cells or in CF HAE infected with PIVGFP (ii). Robust apical domain CFTR and GFP were detected in non-CF HAE ciliated cells
inoculated with PIVGFPCFTR and endogenous CFTR levels detected in GFP-negative ciliated cells (iii, arrowheads). Endogenous CFTR was detected at
the apical membranes of GFP-positive and -negative ciliated cells after inoculation with PIVGFP (iv, arrowheads). Bar represents 5 mm. (D)
Representative traces of short-circuit current measurements (Isc) from CF HAE 48 h pi by PIVCFTR, PIVGFP, or mock showing post amiloride responses
to sequentially added forskolin (Fsk), and CFTR172. A representative Fsk-induced Isc response by a non-CF HAE is shown for comparison. No Fsk
responses were seen in CF HAE inoculated with PIVGFP or mock, consistent with the absence of CFTR. (E) Summary data for Fsk-activated changes in
Isc (DIsc) in CF HAE 48 h pi with mock, PIVGFP, PIVDF508CFTR, or PIVCFTR. Fsk responses for non-CF HAE are shown as comparison. CFTR delivery to
ciliated cells resulted in restoration of functional Cl2 channel activity in CF HAE to levels exhibited in non-CF HAE. Each bar represents at least 11
cultures from four different patients. ns denotes not significantly different. Error bars indicate SEM.
doi:10.1371/journal.pbio.1000155.g003
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inoculated with PIVCFTR expressed large amounts of mature
CFTR (Figure 3B, lane 3, band C), whereas no mature CFTR
protein was detected in CF HAE inoculated with vehicle alone
(lane 1) or PIVGFP (lane 2). Serial 10-fold dilutions of total protein
lysates of CF HAE inoculated with PIVCFTR (lanes 4 and 5)
provided a semiquantitative measurement of the amounts of
exogenous CFTR protein in CF HAE compared to CFTR protein
levels in non-CF HAE (lane 6). We estimate that an approximately
50-fold increase in mature CFTR protein in transduced CF HAE
was achieved compared to non-CF HAE. Therefore, two
independent measures of CFTR abundance indicate a significant
overexpression of both CFTR mRNA and protein in transduced
CF HAE. Note, these measures are likely an underestimate given
that not all ciliated cells are infected by PIVCFTR. Because
approximately 60% of ciliated cells were infected in these
experiments, and ciliated cells on average comprise approximately
70% of surface cells within a culture, we estimate that individual
infected ciliated cells likely overexpress CFTR protein by at least
100-fold over non-CF ciliated cells.
Apical localization and overexpression of CFTR above
endogenous levels in ciliated cells was confirmed by immunode-
tection of CFTR in CF HAE and non-CF HAE (Figure 3C). For
these studies, we chose to engineer both GFP and CFTR into a
single PIV vector (PIVGFPCFTR) to enable identification of
infected cells by GFP fluorescence. In CF HAE infected with
PIVGFPCFTR, CFTR was immunolocalized only to ciliated cells
that were also positive for GFP (Figure 3Ci) and concentrated in
apical membrane domains at the base of the cilial shafts. Although
endogenous CFTR in non-CF ciliated cells in vitro is localized to
these regions [3], subapical membrane CFTR immunoreactivity
was also detected after PIVGFPCFTR, likely suggesting the
increased presence of CFTR in recycling endosomes. Infection of
CF HAE with PIVGFP alone showed that ciliated cells positive for
GFP were negative for CFTR immunoreactivity (Figure 3Cii).
When non-CF HAE were infected by PIVGFPCFTR, endogenous
CFTR was present in GFP-negative ciliated cells and overex-
pressed in GFP-positive cells (Figure 3Ciii). For non-CF HAE
infected with PIVGFP, GFP-positive and -negative ciliated cells
showed only endogenous CFTR apical membrane immunoreac-
tivity (Figure 3Civ). CFTR (endogenous or PIV-delivered), GFP,
or PIV antigens were never detected in cell types that did not
posses cilia (Figure S3).
To determine whether PIV-mediated CFTR delivery to ciliated
cells resulted in functional CFTR anion channel activity in CF
HAE, we maximally stimulated cAMP-mediated anion transport
capacity using forskolin (Fsk), an activator of CFTR. Figure 3D
shows bioelectric short-circuit current (Isc) traces obtained in
Ussing chamber experiments with CF HAE inoculated with mock
(vehicle alone), PIVGFP, or PIVCFTR. For comparison, a Isc
trace from a non-CF HAE is also shown. Whereas Isc responses to
Fsk were not observed in mock- or PIVGFP-inoculated CF HAE,
CF HAE inoculated with PIVCFTR exhibited rapid and sustained
increases in Isc that were rapidly inhibited by a CFTR-specific
inhibitor (CFTR172 [20]). Experiments using CF cells derived from
four different donors revealed that the kinetics and magnitudes of
the Fsk responses in PIVCFTR-corrected CF HAE were
indistinguishable from those observed for non-CF HAE
(Figure 3D and 3E; range 6.7–42.0 mA/cm2 for PIVCFTR, 0–
1.5 mA/cm2 for CF HAE controls [mock and PIVGFP] and 7.8–
70.3 mA/cm2 for non-CF HAE). An additional control using PIV
expressing the nonfunctional CFTR mutant DF508CFTR
(PIVDF508) confirmed that functional CFTR was required for
bioelectric correction of CF HAE (Figure 3E). These data show
that delivery of functional CFTR to CF ciliated cells fully restored
maximally stimulated CFTR anion channel activity to normal
non-CF levels. PIVCFTR did not significantly affect UTP-
mediated Cl2 secretion in CF HAE beyond that of PIVGFP
(Figure S4).
Overexpression of CFTR in CF Ciliated Cells Does Not
Increase Anion Transport Beyond That of Non-CF HAE
Although others have shown that overexpression of CFTR was
not detrimental to airway epithelial cell integrity in vitro and in
vivo [21,22], we had anticipated that Fsk-stimulated Cl2 secretion
would exceed that of non-CF HAE since CF ciliated cells
significantly overexpressed CFTR, i.e., CF HAE would be
‘‘supercorrected.’’ That CF HAE overexpressing CFTR exhibited
identical anion secretion as measured in non-CF HAE with
endogenous CFTR levels suggested that the ceiling for anion
secretion rates was not solely related to the absolute quantity of
CFTR present in ciliated cells. Several explanations appeared
plausible to account for this observation.
A first explanation is that transduced CFTR was not trafficked
to the apical membrane of CF ciliated cells. As shown in Figure 3C,
this was not the case, as immunofluorescent localization revealed
clear targeting of transduced CFTR to apical domains of CF
ciliated cells. It is possible, however, that not all correctly trafficked
CFTR was inserted into the apical membrane in regions that
facilitate function. Certainly, our immunolocalization data suggest
CFTR is present in subapical membrane structures likely
representing recycling endosomes.
A second explanation is that overexpression of CFTR resulted
in mislocalization of a fraction of CFTR to basolateral membranes
of ciliated cells. This event would be predicted to dampen Fsk-
induced CFTR responses as suggested for adenovirus-mediated
CFTR delivery to airway epithelia [23]. Although CFTR
immunoreactivity was restricted to the apical domains of ciliated
cells, even when overexpressed (Figure 3C), we further tested for
this possibility by using CFTR172 as a probe to measure CFTR
functional activity in apical and/or basolateral compartments of
PIVCFTR-corrected CF HAE. Addition of CFTR172 to apical
surfaces 15 min before or during Fsk-induced anion secretion
resulted in rapid and complete inhibition of secretion (Figure 4A).
In contrast, CFTR172 applied to basolateral surfaces before or
during Fsk-induced anion secretion had no effect on Fsk-induced
anion secretion, suggesting that no significant functional CFTR
was present in the basolateral membranes of ciliated cells.
A third explanation is that the Fsk responses are limited by the
apical membrane driving force for Cl2 secretion. We tested this
possibility by comparing the Fsk responses with PIVCFTR-
corrected CF HAE (.100-fold increased CFTR) to non-CF HAE
(endogenous CFTR levels) with protocols designed to make the
electrochemical driving force for Cl2 secretion nonlimiting
(bathing solutions changed from Cl2 replete [Krebs bicarbonate
Ringer, KBR] to Cl2 deplete [high potassium low chloride,
HKLC]). As shown in Figure 4B, Fsk responses in CF HAE
overexpressing CFTR and non-CF HAE were similar under
conditions of physiological Cl2 secretory driving forces (KBR).
Importantly, when the apical membrane Cl2 secretory driving
force was made large and not limiting by lumenal Cl2 substitution,
Fsk again stimulated similar responses in CF HAE overexpressing
CFTR compared to non-CF HAE (Figure 4B, HKLC). These
observations strongly suggest that overexpressed levels of CFTR
do not produce reduction in Cl2 secretory driving forces that offset
the additional quantity of CFTR in the apical membrane and
hence buffer the Cl2 secretion rates. As an additional control,
UTP-mediated Cl2 secretion (via calcium-activated Cl2 channels)
was increased .20-fold in HKLC bathing solution compared to
CFTR Delivery to Ciliated Airway Cells
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KBR (Figure 4C), indicating that the maximal anion secretory
capacity of cultures had not been reached.
Collectively, these data suggest that CFTR overexpressed in CF
ciliated cells is selectively trafficked to the apical domains of these
cells. However, a ceiling of CFTR Cl2 secretion is reached that
approximates that of endogenous CFTR in non-CF HAE. We
speculate that this ceiling reflects the limiting requirement of the
number of potential apical membrane docking sites for CFTR
and/or the limited amount of accessory/regulatory proteins
localized at apical membranes of CF cells required for CFTR
function. It is likely that CFTR insertion into the apical
membranes of ciliated cells is tightly regulated with recycling
and replenishment of CFTR governed by CFTR-rich recycling
endosomes. To determine whether limited availability of docking
sites or accessory proteins was unique to CF ciliated cells, non-CF
HAE were inoculated with PIVCFTR and PIVGFP, and Fsk
responses compared (Figure 4D). Overexpression of CFTR in
non-CF HAE provided only moderately increased Fsk-mediated
Cl2 secretion compared to cultures inoculated with PIVGFP.
Although modest but significant differences in resistance were
measured before/after Fsk treatment in mock-treated non-CF
HAE, no significant differences in resistance were measured
before/after forskolin treatment after PIVCFTR versus PIVGFP
inoculations: (Resistances [V.cm2] before/after Fsk: Mock,
550649/40160.5; PIVGFP, 452639/40260; PIVCFTR,
419612/40160.2; n=5 for each). Collectively, these data suggest
replacement of a corrective CFTR gene to CF ciliated cells is the
only manipulation required for correction of the CF defect since
both CF and non-CF HAE regulate CFTR activity similarly.
Restoration of ASL Volume Regulation in CF HAE by
Expressing CFTR in Ciliated Cells
The dehydrated airway surface phenotype characteristic of CF
results from the inability to induce Cl2 secretion and the failure to
regulate Na+ absorption to maintain ASL height at approximately
7–10 mm, i.e., physiologic ‘‘thin-film’’ volumes. We investigated
whether expression of CFTR in CF ciliated cells corrected both
the Cl2 secretory and Na+ hyperabsorptive phenotype of CF HAE
by measuring responses to specific antagonists on transepithelial
potential difference (Vt) with microelectrodes under thin-film
conditions when the height of the ASL was at steady state.
Measurement of the basal contribution of Cl2 transport to Vt by
blocking basolateral membrane cellular Cl2 entry with bumeta-
nide (1024 M) showed that 40% of the Vt in non-CF HAE was
accounted for by Cl2 ion transport (Figure 5A, white bars). In
contrast, in CF HAE, there was no detectable bumetanide-
sensitive Vt, consistent with the absence of functional CFTR (black
bars). However, after PIVCFTR, but not PIVGFP, the contribu-
tion of Cl2 transport to CF HAE Vt was indistinguishable from
that for non-CF HAE (approximately 40%, red bars). These data
obtained under thin-film conditions confirm that delivery of
Figure 4. CFTR activity in ciliated cells is regulated by factors other than CFTR levels. (A) Percentage inhibition of Fsk-activated CFTR by
CFTR172 applied to either the apical (AP) or basolateral (BL) surfaces of PIVCFTR-corrected CF HAE. CFTR activity was inhibited by apical, but not
basolateral, addition of CFTR172 for at least 15 min (n=4). (B) Driving force for Cl
2 secretion does not dictate magnitude of the Fsk response
determined by measurement of Fsk-mediated DIsc under physiological Cl
2 concentration (KBR) or Cl2-free solutions (HKLC) in CF HAE 48 h after
inoculation by PIVGFP (green bars) or PIVCFTR (red bars) and compared to non-CF HAE (white bars) (n=8). (C) UTP-mediated Cl2 secretion in KBR
(solid bars) and HKLC (hatched bars) bathing solutions after inoculation of CF HAE with vehicle alone (black bars), PIVGFP (green bars), or PIVCFTR
(red bars) (n=6). Note that under conditions of increased driving force for Cl2 secretion, responses far exceed the maximal responses achieved with
Fsk-mediated CFTR activation in the presence of overexpressed CFTR. (D) Fsk-induced DISC in non-CF HAE inoculated with mock (black bars), PIVGFP
(green bars), or PIVCFTR (red bars), showing that overexpression of CFTR on top of endogenous CFTR does not significantly enhance the Fsk-
mediated secretory response under physiological conditions (n= 5 for each). ns denotes not significantly different. Error bars indicate SEM .
doi:10.1371/journal.pbio.1000155.g004
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Figure 5. Expression of CFTR in CF ciliated cells restores normal ASL homeostasis and MCT to CF HAE. (A) The contribution of Cl2 and
Na+ to transepithelial electrical potential difference (Vt) under thin-film conditions in CF HAE mock-inoculated (black bars), PIVGFP (green bars), or
PIVCFTR (red bars). Vt changes for non-CF HAE are shown for comparison (white bars). Bar graphs depict percentage change in Vt in response to Cl
2
channel inhibitor bumetanide (Bum) and Na+ channel inhibitor benzamil (Bum/Benz). Each bar represents eight cultures derived from three different
patients, and an asterisk (*) indicates p,0.05, and ns indicates not significant. (B) ASL height measurements 24 h after apical addition of 25 ml of PBS
containing Texas Red dextran to CF HAE 48 h pi with mock (black), PIVGFP (green), or PIVCFTR (red) and compared to ASL height in non-CF HAE
(white). Each bar represents nine cultures from three patients. (C) Cilia beat frequency measurements (CBF in beats per second [bps]) from CF HAE
24 h after the addition of 25 ml of PBS to CF HAE 48 h pi with mock (black), PIVGFP (green), or PIVCFTR (red) and compared to non-CF HAE (white).
Each bar represents six cultures derived from two patients. (D) MCT rates measured 24 h after bead addition to CF HAE inoculated with mock (black),
PIVGFP (green), or PIVCFTR (red). MCT for non-CF HAE are shown for comparison (white). Each bar represents at least nine cultures derived from three
patients. (E) Representative photomicrographs showing time-lapse (3-s exposures) movement 24 h after addition of green fluorescent microspheres
(as an index of MCT) on CF HAE 48 h after inoculation with mock (i), PIVGFP (ii), or PIVCFTR (iii). Note: GFP-positive cells are also observed below
beads in PIVGFP-inoculated CF HAE. Bar represents 60 mm, and asterisk (*) denotes p,0.05, and ns not significantly different compared to non-CF
HAE (iv). Error bars indicate SEM.
doi:10.1371/journal.pbio.1000155.g005
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CFTR to CF ciliated cells fully corrected the Cl2 secretory defect
to non-CF levels.
The epithelial Na+ channel (ENaC) is rate-limiting for Na+
absorption and is negatively regulated by CFTR expression [24–
26]. Since ENaC activity is regulated by mediators present in the
ASL (e.g., nucleotides and proteases [27,28]), and Ussing
chamber (‘‘thick-film’’) studies result in washing away of these
critical ENaC regulatory factors, we determined how CFTR
delivery to CF ciliated cells affected the regulated activity of
ENaC under thin-film conditions using microelectrodes. The
change in Vt, in response to the Na
+ channel blocker, benzamil
(1025 M), indicated that Na+ transport accounted for approxi-
mately 40% of the total Vt in non-CF HAE (Figure 5A, white
bars) and approximately 80% of transport in CF HAE (black
bars), consistent with a Na+ hyperabsorptive phenotype for CF
airway epithelia. Expression of CFTR, but not GFP, in CF
ciliated cells significantly reduced the contribution of CF HAE
Na+ transport to levels measured in non-CF HAE (Figure 5A, red
bars). These data show that delivery of CFTR to CF ciliated cells
restored both Cl2 secretion and the regulation of Na+ absorption
by CF airway epithelia to normal, non-CF HAE levels. The
simplest conclusion drawn from these data is that ENaC and
CFTR both reside in ciliated cells in the human airway
epithelium.
CFTR Expression in CF Ciliated Cells Restores Regulation
of Apical Surface Hydration
During these experiments, it was noted that the lumenal
surfaces of PIVCFTR-corrected CF HAE appeared hydrated
compared to the dehydrated surfaces of CF HAE, suggesting that
the rebalancing of Na+ absorption and Cl2 secretion consequent
to delivery of CFTR to ciliated cells restored hydration to the
lumenal surfaces of CF HAE. Therefore, we initiated experiments
to measure ASL height regulation in CF HAE in the absence or
presence of transduced CFTR in ciliated CF cells.
ASL volume regulation was assessed by measuring ASL height
with XZ-plane confocal microscopy 48 h after addition of 25 ml of
PBS to the apical surfaces of CF HAE. In control CF HAE
(inoculated with mock or PIVGFP), CF epithelia absorbed almost
all fluid from their surfaces, resulting in an ASL height of 3 mm,
i.e., the minimal space of compacted folded-over cilia and
consistent with mucostasis (Figure 5B) [29]. However, in
PIVCFTR-corrected CF HAE, ASL height stabilized at approx-
imately 8 mm, a height similar to that of non-CF HAE (Figure 5B).
These data show that delivery of CFTR to CF ciliated cells fully
restored the regulation of ASL height to levels maintained by non-
CF HAE, thus establishing the critical role of CFTR and ciliated
cells in ASL height homeostasis.
We next investigated whether the depletion of ASL over time
impaired cilia beat by measuring ciliary beat frequency (CBF) of
CF HAE under thin-film conditions. Immediately after addition of
25 ml of PBS to the apical surface of CF HAE, CBF was
approximately 8 Hz, a value not different than exhibited by non-
CF HAE (Figure 5C). However, consistent with the decreased ASL
height in control CF HAE, effective CBF was reduced 48 h later in
CF HAE compared to non-CF HAE (Figure 5C). In contrast,
effective CBF was maintained in PIVCFTR-inoculated, but not
PIVGFP-inoculated, CF HAE at levels similar to those measured
in non-CF HAE (Figure 5C). These data strongly argue that
ineffective cilia beat observed in CF HAE reflects a defect in ASL
height regulation, not ciliary function, and restoration of ASL
height regulation with PIVCFTR is sufficient to restore effective
cilia beat in CF HAE.
CFTR Expression in CF Ciliated Cells Restores Effective
MCT
A novel feature of the HAE model is the recapitulation of MCT,
reflecting coordinated cilia beat that produces rotational flow of
mucus over hydrated epithelial apical surfaces [6]. In CF HAE,
the rotational flow is abolished due to ASL depletion, mimicking
mucostasis described for CF airways in vivo [6]. To determine
whether expression of CFTR in CF ciliated cells could prevent
mucostasis, CF HAE were inoculated with PIVCFTR, PIVGFP,
or mock and, 24 h later, a small bolus of 1-mm fluorescent beads
added to the apical surfaces and cultures maintained at .95%
humidity for 24 h. For control CF HAE, rotational flow of beads
was rarely observed at 48 h pi (Figure 5D, 5Ei, and 5Eii), i.e.,
mucostasis occurred. In contrast, PIVCFTR-corrected CF HAE
exhibited significant rotational flow of beads, indicating that MCT
had been restored (Figure 5D and 5Eiii). Under these conditions at
48 h pi, PIVCFTR restored approximately 50% of the MCT
measured in parallel non-CF HAE (Figure 5D and 5Eiv). These
data are the first demonstration, to our knowledge, that MCT can
be restored to CF airway epithelia by delivering CFTR to ciliated
cells, indicating that the cumulative effects of CFTR deficiency on
mechanical innate defense can be reversed by this strategy.
Why MCT was not completely restored to normal levels,
especially when ion transport processes and ASL volume
regulation were fully corrected, remains to be determined. A
possible explanation may relate to potentially subtle cytopathic
effects of PIV infection at 48 h pi. To address this possibility, we
inoculated non-CF HAE with PIVGFP or PIVCFTR, and
assessed MCT 48 h later. PIVGFP decreased MCT to 4063%
(n=5) of normal levels, whereas PIVCFTR decreased MCT to
approximately 74611% (n=5) of normal levels. These data
strongly suggest that after 48 h of PIV infection, virus-induced
cytopathic events, likely linked to virus replication capacity, limit
complete restoration of MCT to non-CF levels.
Duration of CFTR correction is limited by shedding of PIV-
infected ciliated cells. Experiments to determine the duration of
PIVCFTR-mediated bioelectric correction showed that significant
functional correction was maintained for at least 1 wk with
detectable, but decreased, levels of function remaining at 21 d pi
(Figure 6A). Previously, we have shown that PIV-infected ciliated
cells are shed from HAE 3–7 d pi by a poorly understood process
of extruding infected ciliated cells from the epithelium onto the
lumenal surfaces of HAE [17]. This process likely represents an
innate defense function of the epithelium to rid itself of PIV-
infected ciliated cells. To confirm that PIV-infected ciliated cells
were being shed from the epithelium, we assessed the cellular
composition of apical secretions 6 d after PIVGFP inoculation. By
morphologic and immunodetection of GFP-positive cells and
ciliated cells, we determined that PIV-infected ciliated cells were
shed into apical secretions at a rate far exceeding that of natural
ciliated cell shedding (Figure 6B). Therefore, the temporally
related loss of CFTR functional activity in PIVCFTR-corrected
CF HAE likely reflects shedding of infected ciliated cells and
suggests that the extent of correction is directly related to the
numbers of ciliated cells expressing CFTR. To further explore this
relationship, we counted the numbers of PIV-positive cells present
in CF HAE over time and show that the loss of PIV-positive
ciliated cells paralleled the loss of Cl2 transport (compare
Figure 6C to 6A), suggesting that the magnitude of correction
was indeed directly proportional to the number of CF ciliated cells
expressing CFTR.
Interestingly, although the numbers of PIV-positive ciliated cells
were similar at day 2 and 4 pi for both transgenes (CFTR or GFP),
by day 8 pi, significantly more PIVCFTR-positive ciliated cells
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remained compared to PIVGFP. Because PIVCFTR has a lower
replication capacity than PIVGFP, we speculate that ciliated cell
shedding is related to the rate of virus replication and that
identification or generation of PIV vectors with further attenuated
replication may provide delivery vectors that prolong functional
CFTR correction. Further characterization of the processes
involved in PIV-induced ciliated cell shedding from HAE may
also provide novel strategies to prolong the lifespan of CFTR-
expressing ciliated cells.
Efficacy of CFTR Correction Is Related to the Number of
Surface Epithelial Cells Expressing CFTR
A central question in CF gene transfer studies has been the
efficiency of CFTR delivery required for clinical benefit. For
chemical corrector therapies, efficiency reflects the percent
increase in CFTR function per cell. With respect to gene transfer
studies, when CFTR expression exceeds endogenous levels on a
per cell basis, it may be speculated that efficiency reflects the
number of cells within the epithelium targeted for CFTR delivery.
Given the low endogenous level of CFTR expression in ciliated
cells, coupled with high levels of exogenous CFTR expression
generated from PIV vectors, we performed dose-effect experi-
ments with PIV designed to ask what percentage of CF surface
epithelial cells must be corrected to restore hydration and MCT to
the airway surface in CF HAE.
First, we determined that inoculation of CF HAE with different
concentrations of PIVCFTR (range 103–106 PFU) resulted in
inoculum-dependent increases in the percentage of PIV-positive
cells at 24 h pi (Figure 7A). Increasing numbers of cells expressing
CFTR paralleled increasing CFTR mRNA levels, Fsk-stimulated
Cl2 secretion, and Amil-sensitive Na+ absorption (Figure 7B, 7C,
and 7D).
We next used this approach to determine the percentage of cells
required to express CFTR to restore normal ASL homeostasis and
MCT to CF HAE under thin-film conditions. ASL height and
MCT were measured in CF HAE 24 h after inoculation with
PIVCFTR at different concentrations. PIVCFTR resulted in
concurrent increases in ASL height and MCT rates that were
proportional to the percentages of PIV-positive cells, with a
plateau occurring at approximately 40% of PIV-positive cells
(Figure 7E and 7F). As controls, PIV expressing GFP or
DF508CFTR failed to increase ASL height or MCT rates in CF
HAE (Figures 7E and 7F). By comparison of these data to ASL
height and MCT measurements in non-CF HAE (Figure 7E and
7F, dashed lines), it was noted that ASL height and MCT rates
both plateaued at levels similar to those measured in non-CF
HAE, suggesting that normal homeostasis had been reached. We
Figure 6. Duration of CFTR functional correction is limited by shedding of PIV-infected ciliated cells. (A) Duration of CFTR functional
activity in PIV corrected CF HAE. CF HAE were inoculated with PIVCFTR (red bars) or PIVGFP (green bars) at day 0, and ion transport studies were
performed at days specified (n= 8 cultures derived from 3 different patients). Significant CFTR function could be measured for up to 8 d but waned
by 21 d pi in CF HAE inoculated with PIVCFTR. No significant CFTR function was detected in CF HAE inoculated with PIVGFP. (B) Histological Cytospin
assessment of cells shed into apical surface secretions at day 6 pi showing few shed ciliated cells in mock-inoculated CF HAE (i and iii), whereas
significant numbers of cells were shed after PIVGFP (ii and iv). Cytospinned apical washes were counterstained with Giemsa (i and ii) or probed with
Abs to GFP (green) and acetylated alpha-tubulin (red) to show ciliated cells. Bar represents 20 mm. Images are representative of Cytospins from two
individual experiments. (C) Loss of PIV F-positive cells over time after inoculation with PIVCFTR (red bars) or PIVGFP (green bars), showing that
PIVCFTR and PIVGFP infected equal numbers of ciliated cells at day 2, but that ciliated cell shedding was delayed for PIVCFTR versus PIVGFP by day 8.
Data derived from same dataset in (A). An asterisk (*) denotes p,0.05. Error bars indicate SEM.
doi:10.1371/journal.pbio.1000155.g006
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Figure 7. How many CF airway epithelial cells require CFTR to restore ASL homeostasis and MCT to non-CF HAE levels? (A)
Quantitation of the percentage of PIV F-positive cells 24 h after inoculation with different concentrations of PIVCFTR (103–106 PFU) and correlation of
percentage of PIVCFTR-positive cells to: (B) increased CFTR mRNA expression levels; (C) Fsk-activated changes in Isc; (D) amil-induced changes in Isc;
(E) ASL height; and (F) MCT rates. All measurements were made 24 h after inoculation with PIVCFTR (closed red circles) or controls (PIVGFP or
PIVDF508CFTR, closed green triangles) as described in Materials and Methods. n.11 for each data point representing cultures from 2 or 3 different
donors. Dashed lines and grey shaded regions represent mean and standard deviations of ASL heights and MCT rates measured in parallel
experiments with non-CF HAE. For these experiments, approximately 80% of surface cells were ciliated cells. (G) Schematic representation depicting
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speculate that the plateau levels for ASL height and MCT reflect
homeostatic feedback signals within ASL under the thin-film
conditions, e.g., ATP release rates that regulate ion channel
activity.
By comparison of data obtained in corrected CF HAE to that in
normal non-CF HAE, we calculate that at least 25% of surface
epithelial cells (30% of ciliated cells) required CFTR expression to
restore ASL height regulation to non-CF HAE levels. For MCT,
approximately 40% of cells (50% of ciliated cells) required CFTR
expression to approach MCT rates measured in parallel non-CF
HAE. These data identify the efficiency of epithelial cell CFTR
delivery to restore defective MCT in CF HAE. Of note is the
observation that although PIVCFTR was able to restore MCT to
nearly normal levels, MCT, unlike ASL height, was not fully
restored. This discrepancy is likely related to the cytotoxic effects
of PIV infection on MCT, but not ASL measurements. In these
experiments, performed 24 h after inoculation, MCT restoration
is much improved over that measured at 48 h pi (Figure 5D),
further suggesting that 48 h, but not 24 h, of infection with this
prototypic PIV vector had detrimental effects on MCT. These
data, taken together with those indicating that overexpression of
CFTR on a per cell basis was not detrimental to ion and fluid
transport processes, indicate that gene delivery vectors capable of
targeting at least 25% of the surface airway epithelial cells will be
sufficient to restore ASL height regulation and MCT to levels
comparable to those exhibited in non-CF airway epithelia and that
precise regulation of CFTR levels at least in ciliated cells is not
required.
Discussion
Successful gene transfer to CF airways in vivo has been
principally hampered by a lack of efficacy due to the inefficiency of
gene transfer to human airway epithelium that normally exhibits
CFTR function [30–33]. Although there is clear evidence that
both airway surface and submucosal gland epithelia are dysfunc-
tional in CF, presently, the precise airway regions of the CF lung
that require CFTR delivery for restoration of normal physiological
function and reduction of disease symptoms are not well
established. Although dependent on antibodies used, CFTR has
been localized to human ciliated cells [3] and the fluid-secreting
cells of the submucosal glands [4]. Previously noted physiologic
characteristics of ciliated cells also indicate that ciliated cells
function to maintain airway surface hydration [34]. Certainly,
ciliated cells facilitate effective MCT and airway mucus clearance.
Together, these properties of ciliated cells combined with the
abundance of ciliated cells throughout the human airways make
this cell type a logical, although not exclusive, target for CF lung
gene delivery strategies.
In this study, we have shown that PIV-mediated CFTR delivery
to ciliated cells is efficient and sufficient for correcting the CF
airway epithelium phenotype, i.e., efficient delivery of CFTR to
CF human ciliated airway epithelium corrected hallmark charac-
teristics of CF HAE that mimic the initiating events of CF lung
disease, i.e., abnormal ASL volume homeostasis and mucostasis
(Figures 5 and 7). Abnormal ASL homeostasis in CF airway
epithelium is due to dysregulated Na+ and Cl2 ion transport [35],
both consequent to the absence/dysfunction of CFTR at the
apical membrane [24]. Here, we have demonstrated that delivery
of CFTR to ciliated cells restores Cl2 secretion and reduces the
Na+ hyperabsorption characteristic of the CF airway epithelium in
vitro and in vivo, providing confirmatory evidence that CFTR
functions as both a Cl2 channel and regulator of ENaC within
ciliated cells. Further, we have demonstrated that correction of the
ion channel defects of CF HAE restores the integrated physiology
required for ASL regulation, which ultimately restores MCT
(shown schematically in Figure 7G).
A critical variable for restoration of CFTR functional activity by
PIV is the percentage of cells expressing CFTR. Using CF HAE,
we demonstrate that restoration of normal ASL height and MCT
required CFTR delivery to approximately 25% and approximate-
ly 40% of surface epithelial cells, respectively. We suggest that
restoration of ASL height is the most predictive measure for these
studies, as PIV clearly exerts cytotoxic effects on MCT, but not
ASL measurements. These effects were isolated to MCT, but not
ASL, suggesting that virus-mediated cytotoxicity may affect the
synchrony of cilia beat, leading to modestly reduced effectiveness
of ciliated cells to transport mucus.
Previous studies with gap junction–coupled polarized, but not
differentiated, airway epithelial cell lines suggested that approx-
imately 6%–10% of cells required CFTR to correct the Cl2
transport defect [36], whereas almost all cells (.90%) required
CFTR overexpression to correct ENaC hyperabsorption [21].
Clearly, expression of CFTR in nonciliated airway epithelial cells
would be predicted to increase fluid secretion onto the apical
surfaces of these cells although these previously published studies
did not test this hypothesis. In our studies, we have directly shown
that expression of CFTR in 60% of CF ciliated cells fully corrects
the ENaC hyperabsorption defect (Figure 5A) and that CFTR
expression in approximately 25% of cells (approximately 30% of
ciliated cells) corrects ASL volume homeostasis in CF HAE
(Figure 7E). With respect to ENaC activity after CFTR delivery,
the reasons why our data differ from these previous studies are
unclear, but it may be speculated that differentiated human airway
epithelium models as used in this current study are more
representative and relevant to the required efficiency of CFTR
delivery to human airway epithelium in vivo.
Although our data indicate that CFTR delivery to CF ciliated
cells is sufficient for restoring MCT to CF HAE, it is likely that
delivery of CFTR to other nonciliated surface epithelial cells may
provide functional CFTR activity capable of hydrating the airway
surface. At present, we are not aware of gene delivery vectors
capable of delivering CFTR exclusively to nonciliated cells of
HAE to determine whether CFTR expression in nonciliated cells
also restores MCT. In our studies, we have combined the
requirement of ciliated cells for generation of MCT with CFTR
targeting of CF ciliated cells to restore defective MCT. Since
ciliated cells are the predominant airway surface epithelial cell type
throughout the human conducting airways, vectors targeting at
least ciliated cells may achieve the required efficiency of delivery
for restoration of MCT. We propose that targeting at least ciliated
cells provides efficient and effective CFTR function that is
sufficient for restoration of MCT.
the role of CFTR and ENaC in ASL homeostasis in non-CF airway epithelium; the presence of CFTR modulates ENaC activity and combined regulation
of these ion channels dictates ASL depth regulation at a level sufficient for effective MCT (black arrow). In CF airway epithelium, the absence of CFTR
reduces fluid secretion and leads to dysregulation of ENaC activity overall resulting in hyperabsorption of surface fluid, dehydration of ASL, and
mucostasis with accumulation of mucus plugs. Delivery of CFTR to ciliated cells of CF HAE by PIV restores CFTR function, ENaC regulation, ASL
homeostasis, and MCT. Error bars indicate SEM.
doi:10.1371/journal.pbio.1000155.g007
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Our data using an in vitro model of human airway epithelium
predict that CFTR delivery to 25% of CF airway epithelial cells
will restore MCT to near normal levels. However, it remains to be
determined what proportion of normal MCT rates in vivo would
be beneficial to CF patients. Tracheal mucus velocities in young
smokers are significantly reduced compared to young nonsmokers
(3.4 mm/min versus 10.0 mm/min) but without significant
differences in lung function, perhaps suggesting that MCT at
rates below ‘‘normal’’ may be sufficient to maintain pulmonary
healthy [37]. These in vivo studies measured mucus velocities only
in the trachea, whereas CF lung disease likely initiates in the more
vulnerable, smaller bronchiolar airway regions. If these regions
respond similarly to CFTR delivery, then it is possible that
delivering CFTR to fewer than 25% of CF cells may provide
sufficient MCT to maintain healthy airways. Further testing of this
hypothesis will require appropriate in vivo studies.
Since PIV infects ciliated airway epithelium of hamsters and
human and nonhuman primates, but not those of the murine
airways, testing our PIV vectors in vivo in appropriate models is
difficult. Additionally, it has been recently reported that expression
of human or murine CFTR in ciliated cells of CFTR2/2 mice
failed to correct the nasal epithelium bioelectric defect, although
correction was demonstrated in neonatal, but not adult, tracheal
epithelium [38]. One explanation for these results, in contrast to
our data, is that murine CFTR expressed in murine ciliated cells
may not function correctly. Our study highlights the need to test
vectors for CFTR delivery in appropriate human models and that
such data obtained from CF mouse models require cautious
interpretation. The recent generation of a CF pig model [39,40]
may be beneficial for testing such vector systems, but preliminary
data using ciliated airway epithelial cultures derived from porcine
trachea suggest that this species is also not infected by the human
viruses from which our PIV vectors are generated.
Using our prototypic PIV vector, we could not determine the
lowest limit of CFTR expression on a per cell basis required for
correction since this vector significantly overexpressed CFTR
relative to endogenous levels. In this regard, because CFTR is
critical for regulation of ASL homeostasis, there has been concern
that overexpression of CFTR in CF airways would ‘‘supercorrect’’
Cl2 transport and generate excessive fluid secretion. This concern,
while reasonable, appears unwarranted based on our observations
that ion transport rates and ASL heights in CF HAE after CFTR
delivery did not exceed that measured in non-CF HAE (Figures 3,
5, and 7). These data agree with previously published reports in
which CFTR was transgenically overexpressed in mouse airway
epithelium without deleterious results in terms of cell or organ
toxicity [22]. However, in this transgenic study, CFTR was
overexpressed in Clara cells and alveolar type II cells of the mouse
lung, and so our study represents the first demonstration, to our
knowledge, of the functional safety of CFTR overexpression in
human ciliated cells. Since CFTR overexpression did not super-
correct ASL regulation, we speculate that normal airway
epithelium exhibits multiple apical membrane regulatory mecha-
nisms in addition to CFTR levels that prevent excessive secretion
of fluid into the airway lumen, i.e., airway flooding.
Demonstrating that PIV expresses CFTR at levels in excess of
those required to restore full function to CF HAE suggests that
further attenuation of PIV will be feasible while still providing
sufficient CFTR for functional correction. Indeed, the lower
replication capacity 10-fold reduction of PIVCFTR compared to
PIVGFP, in the context of .100-fold overexpression of CFTR in
individual ciliated cells, suggests that further attenuation of PIV
will continue to provide sufficient CFTR for correction of the CF
MCT defect and possibly further reduce the generation of
inflammatory mediators and cytotoxicity associated with our
PIV vector prototype. The continued effort to develop vaccines
against PIV has generated a wealth of live attenuated recombinant
PIV [41] that exhibit attenuated replication. It is interesting to
note that PIV3 vaccine candidates have been extensively evaluated
after lumenal airway delivery in adults and infants as young as
3 mo [42]; an age of CF patients in which CFTR replacement
would be desirable.
The demonstration of efficacious CFTR gene delivery to human
ciliated airway epithelium overcomes a major hurdle to gene
transfer approaches for CF lung disease. Other strategies to
improve gene delivery to the human airways are ongoing and are
focused on vector development [43–45] and/or manipulation of
the host tissue [46,47]. However, the results so far published have
not shown significant improvement in the ability to deliver
transgenes to human ciliated airway epithelium. Lentiviral-based
vectors pseudotyped with Ebola, influenza virus, baculovirus,
Sendai, or SARS-CoV envelope proteins efficiently transduce
airway epithelial cells in vitro and murine airways in vivo [48–53],
suggesting that combining useful envelope glycoproteins with the
potential longer duration of gene expression afforded by
lentiviruses may provide novel vectors for lung gene transfer
strategies. Similar vectors can be envisioned using the glycopro-
teins of PIV to target lentiviruses to human ciliated airways.
However, to date, none of these vector systems have progressed to
functional studies after delivery of CFTR to human ciliated airway
epithelium, and no demonstration of correction of the CF
phenotype (e.g., ASL height or MCT) has been reported.
Collectively, the studies reported here demonstrate the
efficiency of CFTR delivery to human CF ciliated airway
epithelium that is sufficient to reverse the CF phenotype of ASL
dehydration and mucostasis. Our prototypic PIV vector provides a
useful tool for manipulating ciliated cell function and for
investigating the future potential of delivering functional CFTR
to the airways of CF patients.
Materials and Methods
Construction of PIVCFTR, PIVDF508CFTR, and
PIVGFPCFTR
Recombinant hPIV3 (NC_001796) encoding human CFTR
(NM_000492) or DF508CFTR cDNA or GFP and CFTR as
separate genes was generated from the cDNA antigenome of full-
length hPIV3 JS strain and described in detail in the Supplemental
Methods (Text S1). After rescue, PIV replicated in HEp2 cells to a
titer comparable to the JS wild-type strain (109.1 50% tissue culture
infective dose [TCID50]/ml) suggesting that GFP, CFTR, or
DF508CFTR did not adversely affect the growth capacity of PIV in
producer epithelial cell lines. Virus titers generated by CF HAE
were determined in duplicate by procedures previously described
[17].
Human Airway Epithelial Cell Cultures
Human tracheobronchial tissues were obtained by the Univer-
sity of North Carolina (UNC) CF Center Tissue Culture Core
from airways resected from CF (DF508/DF508 mutation) or non-
CF patients undergoing elective surgery under UNC Institutional
Review Board–approved protocols. Isolated epithelial cells were
obtained and plated at a density of 250,000 cells per well on
permeable Transwell-Col supports (T-Col, 12-mm diameter;
Corning-Costar [13,54]). For bioelectric measurements in Ussing
chambers, cells were plated on type IV collagen-coated Snapwell
supports (Corning-Costar). HAE were generated by provision of
an air–liquid interface for 4–6 wk to form well-differentiated,
CFTR Delivery to Ciliated Airway Cells
PLoS Biology | www.plosbiology.org 13 July 2009 | Volume 7 | Issue 7 | e1000155
polarized cultures that resemble in vivo pseudostratified ciliated
epithelium [13]. Prior to viral inoculation, the apical surfaces of
HAE were rinsed three times over 15 min and inoculated with
100 ml of 107 PFU/ml virus stocks for 2 h at 37uC (unless
otherwise described). After removal of inoculum, HAE were
returned to humidified incubators. Human tracheobronchial
tissues with 1 cm2 of epithelial cell surface area were inoculated
with 100 ml of PIVGFP (107 PFU/ml) or vehicle control for 2 h at
37uC, and then tissues were washed in medium and returned to
the incubator for 24 h in minimal media volume. After fixation in
4% PFA, tissues were paraffin-embedded, and histological sections
were prepared. Immunodetection of GFP was performed as
described below.
Immunodetection Protocols
To determine epithelial cell types infected by PIVGFP in vitro,
HAE were fixed in 4% PFA, permeabilized with 1% Triton X-
100, and ciliated cells identified with mouse primary antibodies
(Ab) against acetylated a-tubulin (Zymed Laboratories) and anti-
mouse IgG-Texas Red (Jackson ImmunoResearch) using confocal
X-Z scanning microscopy. Ex vivo tissues were paraffin-embed-
ded, and histological sections were prepared. GFP signal was
enhanced by indirect immunofluorescence with rabbit anti-GFP
polyclonal Ab (Ab-Cam) and goat anti-rabbit IgG-fluorescein
(Jackson ImmunoResearch). Both in vitro and ex vivo, GFP
colocalized to cells that were also positive for acetylated a-tubulin,
confirming the targeting of ciliated cells in vitro and ex vivo by
PIV.
Immunolocalization of PIV F protein was performed on HAE
fixed in 4% PFA and immunostained either en face or on paraffin-
embedded histological sections. For en face detection, the apical
surfaces of HAE were incubated with PIV3 F-specific monoclonal
Ab (clone 216.16), followed by goat anti-mouse IgG-Alexa-
Fluor594 (Invitrogen). Quantitation of percentages of cells
expressing PIV F protein was performed as described previously
[17] by assessing four different en face fields of the HAE surface
with two cultures obtained from each of three patients. For
histological sections, HAE were immunostained as previously
described [17]. GFP fluorescence was enhanced as described
above. To immunolocalize CFTR in ciliated cells, CF and non-CF
HAE inoculated with PIVGFPCFTR or PIVGFP were gently
scraped with pipette tips and cell suspensions in PBS, immediately
pelleted onto glass slides with Cytospin, and then air-dried.
Following fixation in 4% PFA, CFTR was detected with anti-
human CFTR mouse monoclonal Ab #596 (a gift from Dr. J.
Riordan, University of North Carolina at Chapel Hill) and
Alexafluor594-conjugated goat anti-mouse antibody. Cell nuclei
were counterstained with Hoechst 33342 (Invitrogen). Images
were taken with a Leica SP2 Laser Scanning Confocal
Microscope, and processed with Adobe Photoshop CS2.
To assess ciliated cell shedding induced by PIV, the apical
surfaces of CF HAE inoculated with PIVGFP or mock were
washed in 200 ml of PBS for 30 min, harvested, and washes
pelleted onto glass slides using a StatSpin Cytofuge2 (Iris Sample
Processing) and then air-dried. Slides were then counterstained
with Giemsa (Invitrogen) or probed with rabbit anti-GFP
polyclonal Ab (Ab-Cam) with goat anti-rabbit IgG-fluorescein
(Jackson ImmunoResearch) and Ab against acetylated a-tubulin
(Zymed Laboratories) with anti-mouse IgG-Texas Red (Jackson
ImmunoResearch). Cell nuclei were counterstained with Hoechst
33342 (Invitrogen). Fluorescent confocal images and DIC were
taken with Leica SP2 Laser Scanning Confocal Microscope.
Image processing and overlay were done with Adobe Photoshop
CS2.
Western blot analyses of CFTR protein was performed on HAE
lysed in M-PER buffer (Pierce). Equal amounts of total protein
(850 mg) per sample were adjusted to 1 ml volume with lysis buffer
and added to 2 ml of anti-CFTR Ab #596, followed by 50 ml of
immobilized-protein G agarose bead slurry (Pierce). Proteins were
released from beads with sample buffer, separated with a
NuPAGE 3%–8% Tris-Acetate Gel (Invitrogen), and transferred
to PVDF membranes. The membranes were then incubated with
anti-CFTR Ab (#596) followed by goat anti-mouse IgG-HRP
(Jackson ImmunoResearch), and CFTR were visualized with
SuperSignal West Dura Substrate (Pierce).
Quantitative Reverse Transcriptase PCR for CFTR
Total RNA was isolated HAE after inoculation with either
PIVCFTR, PIVGFP, or vehicle alone using acid phenol-guanidine
thiocyanate followed by DNase digestion and further purification
using the Qiagen RNeasy Mini Kit. RNA from three individual
CF HAE per inoculation was pooled and first-strand cDNA was
synthesized with oligo(dT) and SuperScript II reverse transcriptase
(Invitrogen) to ensure amplification of mRNA and not viral
genome RNA. Quantitative PCR was performed using a Roche
LightCycler with the Roche FastStart DNA Master SYBR Green I
Kit according to the manufacturer’s protocols. Using the Light-
Cycler Software version 4.0, levels of CFTR mRNA were
normalized to the level of GAPDH.
Inflammatory Mediator Measurements
Apical and basolateral samples were collected 48 h pi by
applying 0.2 ml of serum-free medium to apical surfaces and
harvested 30 min later. Basolateral samples were harvested from
the basolateral medium. Samples were stored at 280uC before
cytokine analyses using 28-plex Beadlyte Assays (Upstate) with
Luminex technology (see Text S1 for details).
Ion Transport Measurements
HAE were mounted in Ussing chambers for measurement of
transepithelial resistance (Rt), transepithelial potential difference
(Vt), and short-circuit current (Isc) as previously described [55].
HAE were bathed in bilateral Krebs Bicarbonate Ringer solution
(KBR) gassed with 95% O2, 5% CO2, and maintained at 37uC. Vt
was clamped to zero, and pulsed to 610 mV for 0.5 s every 60 s.
The electrometer output was digitized online, and Isc, Rt, and
calculated Vt displayed on a video monitor. Drugs (amiloride
[1025 M], forskolin [1026 M], and UTP [1024 M]) were added
from concentrated stock solutions to either lumenal and/or serosal
surfaces (all obtained from Sigma-Aldrich). CFTR172 (10
25 M)
was synthesized from a local source according to appropriate
standards and used as previously described [20]. CFTR172 was
added to the apical or basolateral bath 15 min before or during
forskolin-activated CFTR ion transport. For the basolateral
studies, CFTR172 did not affect forskolin-activated responses even
when left 15 min until addition of CFTR172 to the contralateral
surface. For the time course of CFTR functional activity
experiments, all CF HAE were inoculated with either PIVGFP
or PIVCFTR at day 0, and on specific days, cultures were
mounted in Ussing chambers for analyses.
For microelectrode measurements of Vt in thin films of ASL,
borosilicate glass microelectrodes (World Precision Instruments)
were filled with 3 M KCl and positioned into the ASL by a
motorized micromanipulator (MC1000e; SD Instruments) con-
nected to a high-impedance electrometer (World Precision
Instruments). A macroelectrode, constructed of polyethylene
tubing containing 3 M KCl/4% agar, was placed in the serosal
bath as the ground. To measure the contribution of basal Cl2 and
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Na+ transport to Vt, bumetanide (10
24 M) and benzamil (1025 M),
respectively, were added to the basolateral bath 10 min prior to
recording, as previously described [35]. To avoid evaporation of the
thin ASL layer in low-humidity environments, 100 ml of immiscible
perfluorocarbon (Fluorinert-77; 3 M Corporation) was added to the
airway surface as previously described [56].
ASL Height Measurements
To visualize the ASL height, 25 ml of PBS containing 0.2% vol/
vol Texas Red-dextran (10 kDa; Invitrogen) was added to the
lumenal surfaces of HAE. This volume of PBS results in an initial
ASL height of approximately 20–30 mm, as previously described
[56]. Images of the Texas Red–labeled ASL are acquired by laser-
scanning confocal microscopy (Zeiss Model 510) using the
appropriate filters, 540 nm excitation/630 nm emission for Texas
Red. Perfluorocarbon was added to the airway surface 10 min
after the addition of the dye to avoid evaporation of ASL as
described above. ASL height was determined by averaging the
height obtained from XZ scans of five predetermined points per
HAE over time [56].
Cilia Beat Frequency Measurements
HAE were rinsed three times with PBS, then placed on an
inverted phase contrast microscope (TE 2000; Nikon) to record
cilial movement with a 206objective. High-speed (125 Hz) video
images were captured with an eight-bit b/w camera (GS-310
Turbo; Megaplus). The analog signal was digitized via an analog-
to-digital converter board (A/D; National Instruments). A digital
computerized CBF analysis system was used to analyze the
acquired video images, using specialized software, based on
Sisson-Ammons Video Analysis [57].
Measurement of MCT Rates
HAE were removed from a well-humidified incubator and
washed three times with PBS, and green fluorescent microspheres
(0.02% vol/vol, 1 mm; Invitrogen) were added to apical surfaces in
20 ml of PBS and then HAE immediately returned to the
incubator. The rate of microsphere displacement was measured
from time-lapse fluorescent images (488 nm excitation/530 nm
emission) acquired for 3 s with an inverted epifluorescence
microscope (Eclipse; Nikon) and a charge-coupled device (CCD)
camera (OrcaER; Hamamatsu). Angular bead transport velocity
was calculated as previously described [6].
Statistics
All data are expressed as means6standard error of the mean
(SEM) and followed normal distribution as assessed by a standard
Normality Test (Kolmogorov-Smirnov). Unpaired Student t-test
was used to assess the difference between groups. One-way
ANOVA was performed when more than two groups were
compared with a single control, and then the differences between
individual groups within the set assessed by a multiple-comparison
test (Tukey) when the F was ,0.05. A p-value of ,0.05 was
considered significant.
Supporting Information
Figure S1 Schematic representation of construction of
PIVCFTR, PIVDF508CFTR, and PIVGFPCFTR. The cod-
ing sequence for CFTR was inserted into the downstream
noncoding region of the HN gene. Nucleotides 8598–8603 of the
PIV3 genome were modified into a StuI site, which was used to
accept a linker that contained the PIV3 gene-end (GE), intergenic
(IG), and gene-start (GS) transcription signals, followed by SacII
and ApaI sites. These latter sites were used to accept a SacII-ApaI
fragment containing the open reading frame for CFTR (shaded
rectangle, with ATG and TAG initiation and termination codons
indicated). PIVGFPCFTR was constructed with the same strategy
as for PIVCFTR, except with the PIVGFP backbone. Thus,
PIVGFP-CFTR expresses two transgenes, GFP and CFTR,
simultaneously.
Found at: doi:10.1371/journal.pbio.1000155.s001 (0.41 MB TIF)
Figure S2 Inflammatorymediators secreted byCFHAE in
response to PIVGFP or PIVCFTR. Luminex bead-based
quantitation of inflammatory mediators secreted into apical (positive
of abscissa) and basolateral (negative of abscissa) compartments of CF
HAE 48 h pi with mock (vehicle control alone) (black bars), UV-
inactivated PIVGFP (hatched bars), PIVGFP (green bars), or
PIVCFTR (red bars). CXCL-10, IL-6, IL-12p40, MCP-1, RANTES,
andCXCL-8 were the only analytes of 27 tested that were significantly
altered by virus infection. In all cases, PIVCFTR infection resulted in
decreased secretion of inflammatory mediators compared to PIVGFP
and reducing secretion to that measured after UV-PIVGFP alone
(n=4 for each point, ns denotes not statistically significant differences).
Found at: doi:10.1371/journal.pbio.1000155.s002 (0.52 MB TIF)
Figure S3 PIV Infection and CFTR is only detected in
ciliated cells. CFTR or PIV antigens were immunodetected with
anti-CFTR # 596 (red) or rabbit polyclonal anti-PIV (green),
respectively. (A) CFTR was detected in PIVCFTR-inoculated non-
CF ciliated cells as well as noninoculated ciliated cells. (B) In CFHAE,
PIVCFTR only infected ciliated cells and expressed transduced
CFTR. No CFTR or PIV antigen was detected in nonciliated cells
(arrowheads). (C) Endogenous CFTR was only detected in ciliated
cells from non-CF HAE. For (B and C), arrowheads show absence of
CFTR in nonciliated cells. Bar represents 10 mm.
Found at: doi:10.1371/journal.pbio.1000155.s003 (6.24 MB TIF)
Figure S4 Effect of PIV-mediated CFTR expression in CF
HAE on UTP-mediated Cl2 secretion and transepithelial
resistance.Changes in UTP-mediated Isc responses (hatched bars,
left ordinate) and transepithelial resistance (grey bars, right ordinate)
48 h pi with vehicle alone, PIVGFP, or PIVCFTR. PIV infection of
CF HAE resulted in a potentiated UTP response over vehicle
control but did not significantly affect transepithelial resistances.
Found at: doi:10.1371/journal.pbio.1000155.s004 (0.37 MB TIF)
Text S1 Additional methodologies are described. These
include the detailed procedures for the molecular constructions of
recombinant PIV vectors (PIVCFTR, PIVDF508CFTR, and
PIVGFPCFTR), the oligonucleotide sequences for primers used
for qRT-PCR assays, and the list of inflammatory mediators
measured by Luminex multiplex assays.
Found at: doi:10.1371/journal.pbio.1000155.s005 (0.03MBDOC)
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